Oncotarget

Research Papers:

CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer

Mengjiao Han, Dongjun Dai, Neelum Aziz Yousafzai, Faliang Wang, Hanying Wang, Qiying Zhou, Haiqi Lu, Wenxia Xu, Lifeng Feng, Hongchuan Jin and Xian Wang _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:103557-103567. https://doi.org/10.18632/oncotarget.21581

Metrics: PDF 1884 views  |   HTML 2574 views  |   ?  


Abstract

Mengjiao Han1, Dongjun Dai1, Neelum Aziz Yousafzai1, Faliang Wang2, Hanying Wang1, Qiying Zhou1, Haiqi Lu1, Wenxia Xu2, Lifeng Feng2, Hongchuan Jin2 and Xian Wang1

1Department of Medical Oncology, Sir Run Run Shaw Hospital, Medical School of Zhejiang University, Hangzhou, China

2Labortaory of Cancer Biology, Key Laboratory of Biotherapy in Zhejiang, Sir Run Run Shaw Hospital, Medical School of Zhejiang University, Hangzhou, China

Correspondence to:

Xian Wang, email: [email protected]

Keywords: CXXC4, GDF15, apoptosis, gastric cancer

Received: June 30, 2017     Accepted: September 05, 2017     Published: October 06, 2017

ABSTRACT

Worldwide, gastric cancer is one of the most fatal cancers. Epigenetic alterations in gastric cancer play important roles in silencing of tumor suppressor genes. We previously found that CXXC finger protein 4 (CXXC4) was a novel tumor suppressor in gastric cancer. In this report, we demonstrated that CXXC4 inhibited growth of gastric cancer cells as a pro-apoptotic factor. This inhibition could be reversed by the pan-caspase inhibitor called Z-VAD-FMK. However, CXXC4 with mutations in its DNA binding domain failed to induce apoptosis. Growth differentiation factor 15 (GDF15) was identified as one of potential targets responsible for CXXC4-induced apoptosis. CXXC4 activated GDF15 transcription through enhancing the interaction of transcription factor Sp1 with GDF15 promoter. In summary, the nuclear protein CXXC4 activated apoptosis in gastric cancer through up-regulating its novel potential downstream target GDF15. GDF15 might be a promising target for clinical treatment of gastric cancer with CXXC4 deficiency.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 21581